What is the recommended dosage of Levolin (levosalbutamol) for a child requiring nebulization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levolin (Levosalbutamol) Nebulization Dosing for Children

For children with acute asthma exacerbations, administer levosalbutamol 0.075 mg/kg (minimum dose 1.25 mg) via nebulizer every 20 minutes for 3 doses, then 0.075-0.15 mg/kg every 1-4 hours as needed. 1, 2

Weight-Based Dosing Protocol

  • Initial treatment: 0.075 mg/kg (minimum 1.25 mg) nebulized every 20 minutes for the first 3 doses 1, 2
  • Maintenance dosing: 0.075-0.15 mg/kg every 1-4 hours based on clinical response 1, 2
  • Maximum single dose: 5 mg per treatment 2
  • For very young children under 5 years, consider starting with the lower end of the dosing range 2

Key Dosing Advantage

Levosalbutamol provides equivalent bronchodilation at half the milligram dose of racemic albuterol, meaning 0.63 mg levosalbutamol equals 1.25 mg racemic albuterol in efficacy. 1, 3, 2 This is because levosalbutamol contains only the therapeutically active R-isomer, while racemic albuterol contains 50% inactive S-isomer. 4, 5

Proper Administration Technique

  • Dilute the dose to a minimum of 3 mL total volume with normal saline for optimal aerosol delivery 3, 6, 2
  • Use oxygen-driven nebulizer when possible at 6-8 L/min gas flow 2
  • Ensure properly fitted face mask covering both nose and mouth 6
  • Treatment typically takes 10 minutes to complete 7

Severe Exacerbations

For moderate-to-severe cases, add ipratropium bromide 0.25 mg to the first 3 levosalbutamol doses to reduce hospitalization rates. 3, 2 The combination can be mixed in the same nebulizer. 1

Safety Profile Advantages

Levosalbutamol demonstrates fewer cardiovascular side effects compared to equivalent doses of racemic albuterol, particularly less tachycardia and QTc prolongation. 8, 5 The 0.31 mg dose in children aged 4-11 years showed no significant difference from placebo for heart rate changes, QTc interval, or glucose elevation. 5

Common side effects to monitor include:

  • Tremor (1% incidence) 9
  • Palpitations (0.9% incidence) 9
  • Hypokalemia (monitor with frequent dosing) 5

Clinical Response Monitoring

Reassess after each 20-minute treatment cycle using respiratory rate, heart rate, oxygen saturation, and clinical asthma score. 8 Response to treatment is a better predictor of hospitalization need than initial severity. 3, 6

Alternative Delivery Method

For mild-to-moderate exacerbations, an MDI with spacer (4-8 puffs of 45 mcg levosalbutamol every 20 minutes) is equally effective when proper technique is used. 3, 2 However, nebulizers are preferred for severe exacerbations or when children cannot cooperate with spacer devices. 1, 7

Important Caveat

Levosalbutamol has not been adequately studied for continuous nebulization protocols, so stick with intermittent dosing schedules. 1, 3, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Recommended Dose of Nebulised Levosalbutamol in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Albuterol Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.